LXRX vs MSFT: Which Stock is Better?
Side-by-side comparison of Lexicon Pharmaceuticals Inc and Microsoft Corporation in 2026
LXRX
Lexicon Pharmaceuticals Inc
$2.19
MSFT
Microsoft Corporation
$495.83
Key Metrics Comparison
| Metric | LXRX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $327.22M | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | LXRX |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 710.4% | 18.4% | LXRX |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze LXRX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LXRX or MSFT a better investment?
Comparing LXRX and MSFT: Lexicon Pharmaceuticals Inc has a market cap of $327.22M while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LXRX and MSFT?
LXRX (Lexicon Pharmaceuticals Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LXRX or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: LXRX or MSFT?
LXRX has higher revenue growth at 710.4% vs 18.4% for MSFT.
Which company is more profitable: LXRX or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for LXRX.
Which is the larger company: LXRX or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $327.22M for LXRX.
Should I buy LXRX or MSFT in 2026?
Both LXRX and MSFT have investment merit. LXRX trades at $2.19 while MSFT trades at $495.83. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LXRX and MSFT stock?
Key differences: Market Cap ($327.22M vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (710.4% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy LXRX or MSFT in 2026?
The choice between LXRX and MSFT depends on your investment goals. LXRX shows higher revenue growth (710.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between LXRX and MSFT?
LXRX (Lexicon Pharmaceuticals Inc) has a market cap of $327.22M, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.